OPIANT PHARMACEUTICALS, INC. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/17628f33-b333-4e17-b614-008433713c03/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $40.7M | 2021-01-01 – 2021-12-31 | evidence 0001385508-22-000038 |
| FY 2020 | $27.4M | 2020-01-01 – 2020-12-31 | evidence 0001385508-22-000038 |
| FY 2019 | $40.5M | 2019-01-01 – 2019-12-31 | evidence 0001385508-20-000039 |
| FY 2018 | $14.0M | 2018-01-01 – 2018-12-31 | evidence 0001385508-20-000039 |
| FY 2017 | $15.6M | 2017-01-01 – 2017-12-31 | evidence 0001385508-19-000028 |
| FY 2016 | $9.9M | 2015-08-01 – 2016-07-31 | evidence 0001144204-16-130283 |
| FY 2015 | $1.6M | 2014-08-01 – 2015-07-31 | evidence 0001144204-15-060795 |
| FY 2012 | $0 | 2005-06-21 – 2013-01-31 | evidence 0001185185-13-000533 |
| FY 2011 | $0 | 2005-06-21 – 2012-04-30 | evidence 0001185185-12-001341 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
OPIANT PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income